Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CLBT Cellebrite DI Ltd
- Stocks
- Technology
- NASDAQ: CLBT
Price (delayed)
$15.2
Market cap
$3.61B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.89
Enterprise value
$3.53B
Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and
Highlights
The gross profit has increased by 22% YoY and by 4.1% QoQ
CLBT's revenue is up by 22% YoY and by 4.5% QoQ
The net income has dropped by 74% year-on-year but it is up by 31% since the previous quarter
Cellebrite DI's EPS has shrunk by 53% YoY but it has increased by 34% QoQ
Key stats
What are the main financial stats of CLBT
Market
Valuations
Earnings
Shares outstanding
237.25M
Market cap
$3.61B
Enterprise value
$3.53B
Price to earnings (P/E)
N/A
Price to book (P/B)
10.01
Price to sales (P/S)
8.6
EV/EBIT
58.84
EV/EBITDA
50.03
EV/Sales
8.41
Revenue
$419.17M
Gross profit
$352.35M
Operating income
$59.93M
Net income
-$194.24M
EBIT
$59.93M
EBITDA
$70.49M
Free cash flow
$131.56M
Per share
Balance sheet
Liquidity
EPS
-$0.89
EPS diluted
-$0.89
Free cash flow per share
$0.55
Book value per share
$1.52
Revenue per share
$1.77
TBVPS
$2.83
Total assets
$709.89M
Total liabilities
$346.4M
Debt
$10.6M
Equity
$363.49M
Working capital
$235.68M
Debt to equity
0.03
Current ratio
1.82
Quick ratio
1.7
Net debt/EBITDA
-1.13
Margins
Efficiency
Dividend
EBITDA margin
16.8%
Gross margin
84.1%
Net margin
-46.3%
Operating margin
14.3%
Return on assets
-30%
Return on equity
-81.1%
Return on invested capital
28%
Return on capital employed
14.2%
Return on sales
14.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CLBT stock price
How has the Cellebrite DI stock price performed over time
Intraday
-3.86%
1 week
-6.4%
1 month
-7.03%
1 year
25.41%
YTD
-31%
QTD
-5%
Financial performance
How have Cellebrite DI's revenue and profit performed over time
Revenue
$419.17M
Gross profit
$352.35M
Operating income
$59.93M
Net income
-$194.24M
Gross margin
84.1%
Net margin
-46.3%
The net income has dropped by 74% year-on-year but it is up by 31% since the previous quarter
CLBT's operating income is up by 42% YoY and by 5% from the previous quarter
The net margin has contracted by 42% YoY but it has grown by 34% from the previous quarter
The gross profit has increased by 22% YoY and by 4.1% QoQ
Price vs fundamentals
How does CLBT's price correlate with its fundamentals
Growth
What is Cellebrite DI's growth rate over time
Valuation
What is Cellebrite DI stock price valuation
P/E
N/A
P/B
10.01
P/S
8.6
EV/EBIT
58.84
EV/EBITDA
50.03
EV/Sales
8.41
Cellebrite DI's EPS has shrunk by 53% YoY but it has increased by 34% QoQ
The equity is up by 8% since the previous quarter
The P/S is 46% above the 5-year quarterly average of 5.9 but 9% below the last 4 quarters average of 9.5
CLBT's revenue is up by 22% YoY and by 4.5% QoQ
Efficiency
How efficient is Cellebrite DI business performance
CLBT's ROE has soared by 89% YoY and by 59% from the previous quarter
CLBT's return on assets is up by 36% since the previous quarter but it is down by 32% year-on-year
CLBT's return on invested capital is down by 36% year-on-year and by 14% since the previous quarter
Cellebrite DI's return on sales has increased by 16% YoY
Dividends
What is CLBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CLBT.
Financial health
How did Cellebrite DI financials performed over time
The total assets is 105% more than the total liabilities
Cellebrite DI's total liabilities has decreased by 38% YoY and by 2.3% from the previous quarter
The total assets has grown by 34% YoY and by 2.8% from the previous quarter
The debt is 97% less than the equity
The debt to equity has surged by 106% year-on-year
The debt has contracted by 18% YoY and by 3.3% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.